Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Polyketide synthesis in vitro on a modular polyketide synthase

K E Wiesmann1, J Cortés, M J Brown

  • 1Cambridge Centre for Molecular Recognition, University of Cambridge, UK.

Chemistry & Biology
|September 1, 1995
PubMed
Summary

Researchers purified a chimeric enzyme from Saccharopolyspora erythraea, enabling in vitro studies of polyketide synthase mechanisms. This breakthrough facilitates analysis of complex multienzyme systems involved in antibiotic biosynthesis.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Analysis of UGT1A1 germline variants in patients with advanced breast cancer treated with trastuzumab-deruxtecan: results from the PROCURE Project.

ESMO open·2026
Same author

A chemotherapy-free, pathological response-adapted strategy using trastuzumab-pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

The emerging role of the microbiome in bladder cancer: prognostic implications and treatment response.

Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas·2026
Same author

Datopotamab deruxtecan in patients with untreated, advanced triple-negative breast cancer (TROPION-Breast02): a randomised, open-label, international, phase III trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2026
Same author

Sacituzumab govitecan in patients with metastatic breast cancer: pooled safety analysis of data from patients in North America, Europe, and Asia.

ESMO open·2026
Same author

Human epidermal growth factor receptor 2 (HER2) expression dynamics between diagnosis and recurrence in patients with breast cancer using artificial intelligence and electronic health records: the RosHER study.

ESMO real world data and digital oncology·2026

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Enzymology

Background:

  • The 6-deoxyerythronolide B synthase (DEBS) is a complex multienzyme responsible for synthesizing the erythromycin A antibiotic core.
  • Its intricate structure with numerous active sites has hindered detailed mechanistic studies.
  • A previously engineered mutant fused the DEBS1 enzyme with its chain-terminating cyclase domain (TE).

Purpose of the Study:

  • To purify the engineered DEBS1-TE chimeric enzyme.
  • To characterize its catalytic activity in vitro.
  • To enable future mechanistic and structural analyses of modular polyketide synthases.

Main Methods:

  • Genetic engineering of Saccharopolyspora erythraea to create a DEBS1-TE fusion protein.
  • Purification of the chimeric DEBS1-TE multienzyme.

Related Experiment Videos

  • In vitro enzymatic assays to assess catalytic activity.

    • Main Results:

    • The purified DEBS1-TE enzyme successfully synthesized triketide lactones in vitro.
    • The enzyme demonstrated specific utilization of the (2S)-isomer of methylmalonyl-CoA.
    • A relaxed specificity for the starter unit was observed compared to in vivo conditions.

    Conclusions:

    • A functional, purified polyketide synthase system was successfully obtained.
    • This purified system retains catalytic activity, paving the way for detailed mechanistic investigations.
    • The approach is applicable to diverse modular polyketide synthases for future research.